Nav: Home

NCI renews funding for San Diego Universities, community health centers to work together

September 28, 2015

A collaborative program aimed at reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San Diego State University and Moores Cancer Center at UC San Diego Health.

"By renewing this unique partnership, NCI is recognizing the success and commitment of UC San Diego and San Diego State University to outstanding science, research education, and community outreach," said Scott Lippman, MD, director of Moores Cancer Center. "Cancer continues to be the leading cause of death for Hispanics, but together we are advancing research and closing the gap on cancer disparities in this community."

The SDSU/UCSD Cancer Center Comprehensive Partnership, one of only 12 programs funded through NCI's Comprehensive Partnerships for the Advancement of Health Equity, will support 30 joint research projects, research education programs for undergraduate students of underrepresented racial and ethnic groups who are studying cancer and cancer disparities as well as collaborations with community partners, researchers and students.

"There are needs not being addressed in cancer education, prevention and care among Hispanics," said Maria Elena Martinez, PhD, UC San Diego School of Medicine professor of family medicine and public health and Moores Cancer Center's principal investigator on the SDSU/UCSD cancer partnership. "This partnership helps to reduce disparities by taking a comprehensive approach with the help of 29 community partners representing stakeholders in the Hispanic community in San Diego and Imperial counties."

Hispanics have the highest rates for certain types of leukemia as well as cancers associated with infection, such as liver, stomach and cervical. Although Hispanics are less likely to develop the most common forms of cancers than non-Hispanic whites, such as breast, colon and prostate, they are more likely to be diagnosed with advanced stages of these cancers and less likely to survive after diagnosis. This is due in part to lower than average health screenings.

"The Partnership will provide an opportunity for investigators from various levels to conduct innovative research which will strengthen the cancer research agenda at SDSU and UC San Diego," said Elva Arredondo, PhD, San Diego State University associate professor in the Graduate School of Public Health. "The grant will build on existing community partnerships and link SDSU and UC San Diego with new community organizations. These efforts will help address cancer disparities evident among racial/ethnic groups, including Hispanic communities."

As an official Hispanic Serving Institution, a designation of the federal government that means the university is eligible for extra resources to expand educational opportunities for and improve the attainment of Hispanic students, San Diego State University has strong ties to the Hispanic community. Together with Moores Cancer Center, an NCI-designated Comprehensive Cancer Center with world-renown research, the two institutions can achieve much more than either can on their own, said Martinez.

The SDSU/UCSD Cancer Center Comprehensive Partnership is headed by Martinez, co-leader of the Reducing Cancer Disparities research program at Moores Cancer Center, and Arredondo of San Diego State University, with Sheila Crowe, MD, UC San Diego professor of medicine and director of research in the Division of Gastroenterology, and Mark Sussman, PhD, San Diego State University professor of biology in the College of Sciences.

A close partnership with federally qualified community health centers that care for traditionally underserved Hispanic populations is an innovative feature of the program, which includes a research partnership with San Ysidro Health Centers and a community outreach program with Family Health Centers of San Diego.
Funding for this research came from the National Institutes of Health (2U54CA132379-06A1, 2U54CA132384).

University of California - San Diego

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".